- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chordia Therapeutics Inc (190A)
Chordia Therapeutics Inc stock price live, this page displays TYO 190A stock exchange data. View the 190A premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chordia Therapeutics Inc real time stock price chart below.
What Is the Chordia Therapeutics Inc Stock Price Today?
The Chordia Therapeutics Inc stock price today is 181.00.
What Is the Stock Symbol for Chordia Therapeutics Inc?
The stock symbol for Chordia Therapeutics Inc is ""190A.""
What Stock Exchange Does Chordia Therapeutics Inc Trade On?
Chordia Therapeutics Inc is listed and trades on the Tokyo stock exchange.
Is Chordia Therapeutics Inc a Good Stock to Buy?
Determining whether Chordia Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 190A quote. (ISIN: JP3283730004)
What Is the Chordia Therapeutics Inc Stock Price Today?
The Chordia Therapeutics Inc stock price today is 181.00.
What Is the Stock Symbol for Chordia Therapeutics Inc?
The stock symbol for Chordia Therapeutics Inc is ""190A.""
What Stock Exchange Does Chordia Therapeutics Inc Trade On?
Chordia Therapeutics Inc is listed and trades on the Tokyo stock exchange.
Is Chordia Therapeutics Inc a Good Stock to Buy?
Determining whether Chordia Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 190A quote. (ISIN: JP3283730004)
Tokyo
Currency in JPY
181.00
-3.00(-1.63%)
Closed·
Fair Value
An estimate of a Chordia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
181.00
186.00
52 wk Range
177.00
930.00
190A Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
190A is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Chordia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
181.00186.00
52 wk Range
177.00930.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
190A Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Chordia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Chordia Therapeutics Inc Company Profile
Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. The company was incorporated in 2017 and is based in Fujisawa, Japan.
Compare 190A to Peers and Sector
Metrics to compare | 190A | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship190APeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −8.2x | −0.5x | |
PEG Ratio | - | −0.03 | 0.00 | |
Price/Book | 4.4x | 5.7x | 2.6x | |
Price / LTM Sales | - | 48.5x | 3.3x | |
Upside (Analyst Target) | - | 21.9% | 43.3% | |
Fair Value Upside | Unlock | 11.7% | 6.9% | Unlock |
Earnings
Latest Release
Jul 14, 2025
EPS / Forecast
-6.12 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Chordia Therapeutics Trade On?
Chordia Therapeutics is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Chordia Therapeutics?
The stock symbol for Chordia Therapeutics is "190A."
What Is the Chordia Therapeutics Market Cap?
As of today, Chordia Therapeutics market cap is 12.49B.
What Is Chordia Therapeutics's Earnings Per Share (TTM)?
The Chordia Therapeutics EPS (TTM) is -30.24.
When Is the Next Chordia Therapeutics Earnings Date?
Chordia Therapeutics will release its next earnings report on 09 Oct 2025.
From a Technical Analysis Perspective, Is 190A a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Chordia Therapeutics Stock Split?
Chordia Therapeutics has split 0 times.
How Many Employees Does Chordia Therapeutics Have?
Chordia Therapeutics has 23 employees.
What is the current trading status of Chordia Therapeutics (190A)?
As of 11 Aug 2025, Chordia Therapeutics (190A) is trading at a price of 181.00, with a previous close of 184.00. The stock has fluctuated within a day range of 181.00 to 186.00, while its 52-week range spans from 177.00 to 930.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.